My Ulcerative Colitis Treatment Isn’t Working: What Should I Ask My Doctor Next?

Key takeaways
- Persistent symptoms deserve attention. Ongoing bleeding, diarrhea, urgency, or abdominal pain may indicate active inflammation, although other causes are possible.
- Treatment failure doesn't mean you've exhausted your options. Different medications work through different mechanisms, and another treatment may still be effective.
- Refractory ulcerative colitis requires individual assessment. Your gastroenterologist may consider laboratory tests, stool tests, endoscopy, and previous medication responses.
- Newer treatments offer additional possibilities. Biologics, JAK inhibitors, and S1P receptor modulators have expanded the available treatment options for moderate to severe UC.
- You can take an active role in treatment discussions. Asking about next steps, side effects, insurance coverage, and treatment goals can help you participate in decisions about your care.
You've been taking your ulcerative colitis medication, following your treatment plan, and hoping to feel better. But the symptoms haven't gone away. Or perhaps you felt better for a while, only to notice the urgency, bleeding, or abdominal pain returning.
When your ulcerative colitis treatment isn't working, it's natural to feel frustrated, worried, or unsure about what comes next.
You might wonder whether you need more time, a different dose, or a completely new treatment for ulcerative colitis.
The important thing to know is that not responding to a medication doesn't mean you've run out of options.
Some people with ulcerative colitis (UC) experience persistent inflammation despite treatment. Doctors may describe difficult-to-control disease as refractory ulcerative colitis, although the term can have different meanings depending on the clinical situation.
There are several established and newer treatment options for ulcerative colitis, including biologics and targeted oral medications. Your gastroenterologist can help determine which approaches may be appropriate based on your disease activity, previous treatments, and medical history. [1, 2]
At mama health, patients living with ulcerative colitis have shared their experiences of treatments that didn't work as expected. Their stories highlight an important lesson: asking questions, understanding your options, and feeling heard can make a meaningful difference in how you experience your care.
How can you tell if your ulcerative colitis treatment isn't working?
Ulcerative colitis treatment may not be working adequately when symptoms persist, return, or worsen, but doctors use additional tests to determine whether intestinal inflammation remains active.
Common symptoms that may raise concerns include:
- More frequent bowel movements
- Persistent or recurring rectal bleeding
- Sudden urgency to use the bathroom
- Ongoing diarrhea
- Abdominal pain or cramping
- Fatigue that interferes with everyday activities
- Symptoms returning during corticosteroid tapering
Some people never experience sufficient improvement after starting a medication. Others initially respond well but notice that its effects diminish over time.
However, symptoms alone cannot always establish whether a treatment has failed.
An intestinal infection, irritable bowel syndrome (IBS), or another condition may cause symptoms similar to an ulcerative colitis flare.
The American College of Gastroenterology recommends assessing UC activity using symptoms alongside objective measures of inflammation, including fecal calprotectin, blood tests, and endoscopic findings. [1]
What have patients experienced when treatment stopped working?
In conversations with mama health, patients described recognizing treatment difficulties through changes in their everyday lives.
Some noticed that bathroom visits became more frequent or that urgency made it difficult to leave home.
Others described ongoing bleeding or pain despite taking prescribed medication.
A recurring concern was not knowing whether to give a medication more time or speak to their gastroenterologist about alternatives.
These experiences highlight why clear expectations about treatment response can be valuable.
Questions you could ask your doctor:
- How will we know whether my current medication is working?
- How long should we expect it to take before seeing improvement?
- Would blood tests, stool tests, or a colonoscopy help us understand my symptoms?
- Could something other than active ulcerative colitis be causing these symptoms?
What is refractory ulcerative colitis?
Refractory ulcerative colitis generally describes disease that remains active despite appropriate medical treatment, although the precise definition depends on which therapies have been tried and how treatment response is assessed.
Ulcerative colitis is a chronic inflammatory bowel disease affecting the colon and rectum.
Treatment aims to achieve remission, reduce intestinal inflammation, and maintain disease control over time.
However, not everyone responds to the same medications.
Doctors distinguish between different patterns of inadequate response.
- Primary nonresponse: A medication does not produce an adequate initial response.
- Secondary loss of response: A medication works initially but becomes less effective over time.
- Steroid-dependent UC: Symptoms return when corticosteroids are reduced or stopped, or repeated steroid treatment is needed.
- Steroid-refractory UC: Active disease does not respond adequately to an appropriate corticosteroid course.
- Refractory UC: A broader term for disease that remains inadequately controlled despite suitable treatment approaches.
These distinctions matter because they can influence the next treatment discussion. [1, 2]
For example, a person whose biologic worked initially but later lost effectiveness may face different treatment considerations from someone who never responded to it.
Questions you could ask your doctor:
- Would you describe my ulcerative colitis as refractory or difficult to control?
- Have I experienced primary nonresponse or a loss of response?
- Does my treatment history change which medications we can consider next?
Why might ulcerative colitis medication stop working?
Ulcerative colitis medication may become less effective because disease activity changes, the body develops antibodies against certain biologics, or the medication does not adequately control the inflammatory pathways involved.
Other factors, including interrupted treatment or infections, can complicate the picture.
The medication may not adequately control inflammation
Ulcerative colitis involves complex immune processes.
A medication that targets one inflammatory pathway may work well for some people but not others.
When disease remains active, a gastroenterologist may review whether the current treatment is appropriate for its severity and extent.
The body may develop antibodies against a biologic
Some biologic medications can trigger the development of anti-drug antibodies.
These antibodies may reduce medication effectiveness or contribute to certain treatment reactions.
For people receiving anti-TNF therapies, such as infliximab or adalimumab, doctors may consider measuring medication levels and anti-drug antibodies when treatment response declines.
This is called reactive therapeutic drug monitoring. It can help clinicians evaluate treatment options in selected circumstances. [3]
Treatment interruptions may affect disease control
Missing doses or experiencing gaps in medication access can affect treatment continuity.
In mama health patient conversations, some people described interruptions caused by insurance changes, authorization delays, or difficulty obtaining prescribed medication.
These experiences highlight the importance of discussing access problems with a healthcare team.
Symptoms may have another cause
Not every episode of worsening diarrhea or abdominal discomfort means that UC inflammation has increased.
For example, Clostridioides difficile (C. difficile) infection can cause symptoms that overlap with an ulcerative colitis flare.
Clinical guidance recommends evaluating patients with IBD for this infection when new or worsening diarrhea occurs. [4]
Questions you could ask your doctor:
- What might explain why my medication has stopped helping?
- Could drug levels or antibody testing be useful for my current treatment?
- Do we need to rule out an infection?
- Is there a reason to consider a different treatment approach?
What should you ask your gastroenterologist when treatment isn't working?
When ulcerative colitis treatment isn't working, useful questions focus on confirming disease activity, understanding available alternatives, and agreeing on how the response to treatment will be evaluated.
In mama health patient conversations, some people described wishing they had raised their concerns earlier.
Others recalled remaining on medications that did not adequately control their symptoms because they were unsure what other options existed.
A common theme was wanting a clearer explanation of the treatment plan.
Ask about your current treatment
Understanding why a medication was selected can help you feel more informed.
Questions include:
- Why was this medication chosen for my ulcerative colitis?
- What results were we hoping to achieve?
- Is there evidence that my inflammation is improving?
- Are there reasons to continue the current medication rather than consider an alternative?
Ask about the next step
If the current medication is not providing sufficient benefit, it can be helpful to discuss what other approaches exist.
Questions include:
- What other treatment options for ulcerative colitis could we discuss?
- Is adjusting my current treatment an option?
- Could a biologic or targeted oral medication be appropriate for my situation?
- What factors would influence whether we change treatments?
- When will we reassess the treatment plan?
Ask about remission
Remission is an important goal in ulcerative colitis care.
It may involve improvement in symptoms alongside reduced inflammation seen during medical evaluation.
Questions include:
- What does remission mean in my case?
- Are we aiming for remission without corticosteroids?
- How will we assess whether inflammation has healed?
- What is the longer-term maintenance plan?
These conversations can help clarify what treatment success means beyond simply feeling better for a short period.
What treatment options are available when ulcerative colitis isn't responding?
Treatment options for ulcerative colitis that remains active may include reviewing the current medication, considering a different drug class, or discussing surgery in selected circumstances.
The appropriate approach depends on disease severity, previous treatments, clinical findings, and individual risks.
Reviewing or adjusting an existing treatment
Before selecting another medication, a gastroenterologist may review whether the current treatment has been used for an adequate duration and whether it is suitable for the disease.
For some people receiving certain biologics, dose or dosing-interval adjustments may be considered.
For others, switching therapies may be more appropriate.
These are clinical decisions that depend on the specific medication and the reason for inadequate response.
Biologic therapies
Biologics target components of the immune system involved in inflammation.
Examples include:
- Anti-TNF therapies: Infliximab, adalimumab, and golimumab
- Anti-integrin therapy: Vedolizumab
- Interleukin-targeting therapies: Ustekinumab, mirikizumab, risankizumab, and guselkumab
These medications may be considered for moderate to severe ulcerative colitis.
Some are administered through infusions, while others are available as injections.
Biologics differ in their mechanisms of action, administration schedules, safety considerations, and effectiveness in different patient populations.
Targeted oral therapies
Oral advanced therapies provide additional options for selected adults with moderate to severe UC.
They include:
JAK inhibitors, such as tofacitinib and upadacitinib.
These medications interfere with inflammatory signaling pathways.
They have important safety considerations, including warnings about serious infections, blood clots, cardiovascular events, and certain cancers. Eligibility may depend on previous treatment history and individual risk factors.
S1P receptor modulators, such as ozanimod and etrasimod.
These medicines influence the movement of certain immune cells and are taken orally.
Their use requires assessment of relevant medical conditions, possible drug interactions, and safety precautions.
The American Gastroenterological Association recommends several advanced therapies for moderate to severe UC, with treatment selection influenced by previous medication exposure and individual circumstances. [2]
Surgery
Surgery may be considered when ulcerative colitis remains uncontrolled despite appropriate medical therapy, when serious complications develop, or for certain cancer-related indications.
The main surgical approach involves removing the colon and rectum.
Although surgery has important long-term implications, it can be an effective option in carefully selected situations. [1]
Questions you could ask your doctor:
- What are the benefits and risks of the treatments available to me?
- Could we consider a medication with a different mechanism of action?
- How does my treatment history influence the alternatives?
- What should I know about safety, administration, and maintenance treatment?
Are there new treatments for ulcerative colitis if older medications haven't worked?
Yes. Newer treatment classes and recently introduced medications have expanded the options available for people with moderate to severe ulcerative colitis.
These include therapies targeting interleukin-23 (IL-23), JAK signaling, and sphingosine-1-phosphate (S1P) receptors.
Examples of newer medications include:
- Mirikizumab — Treatment class: IL-23 inhibitor; How it works: Targets the p19 subunit of IL-23 involved in inflammation.
- Risankizumab — Treatment class: IL-23 inhibitor; How it works: Targets IL-23-mediated inflammatory signaling.
- Guselkumab — Treatment class: IL-23 inhibitor; How it works: Blocks IL-23 signaling.
- Upadacitinib — Treatment class: JAK inhibitor; How it works: Inhibits intracellular inflammatory signaling.
- Etrasimod — Treatment class: S1P receptor modulator; How it works: Changes how certain immune cells circulate.
These medications are not interchangeable. Each has its own approved indications, eligibility considerations, safety profile, and administration requirements.
Not every newer treatment will be appropriate for every person with refractory ulcerative colitis.
The AGA living guideline emphasizes that previous advanced therapy exposure can influence the relative effectiveness of later treatment choices. [2]
This also means a medication that is new to the market is not automatically better than an older therapy.
Questions you could ask your doctor:
- Are there newer treatments that may be relevant to my situation?
- How do newer medications compare with the treatment I'm currently taking?
- Would changing to a different drug class make sense?
- Are there any clinical trials that might be relevant to discuss?
When is it worth asking for a second opinion about ulcerative colitis?
A second opinion may be useful when ulcerative colitis remains difficult to control, treatment options are unclear, or you want another specialist's perspective on a complex decision.
Seeking another medical opinion does not necessarily mean your current gastroenterologist has provided inadequate care.
It may simply offer additional information.
In mama health conversations, patients described the importance of feeling heard during appointments.
Some recalled situations where they felt their symptoms were attributed to stress or IBS without a sufficiently clear explanation.
Others appreciated doctors who listened carefully, took their concerns seriously, and explained the available options.
Feeling included in discussions can be especially important when treatment decisions involve potential side effects, long-term medication, or significant changes in everyday life.
You could consider asking:
- Can we review the reasons behind the current treatment plan?
- Would input from an inflammatory bowel disease specialist be helpful?
- Could we discuss the advantages and disadvantages of each available option?
- What other information would help us make this decision together?
A collaborative relationship can make complex treatment discussions easier to navigate.
Can side effects be a reason to discuss switching ulcerative colitis treatments?
Yes. Significant, persistent, or concerning side effects can be valid reasons to review an ulcerative colitis treatment plan with a healthcare professional.
A medication may control inflammation but still cause problems that affect quality of life.
Different therapies have different side-effect profiles.
Corticosteroids, for example, can cause insomnia, mood changes, and other adverse effects, especially with prolonged use.
Biologic medications may cause infusion or injection reactions and can increase the risk of certain infections.
Some advanced oral therapies require additional precautions because of their specific safety risks. [1, 2]
What about symptoms outside the gut?
Ulcerative colitis can also be associated with symptoms outside the digestive system, sometimes called extraintestinal manifestations.
These may involve:
- Joint pain or inflammation
- Eye inflammation
- Skin changes
- Mouth ulcers
However, these symptoms can have other causes, including medication reactions or unrelated conditions.
Patients sharing their experiences through mama health described uncertainty about whether new symptoms came from their disease or their treatment.
This distinction matters because the appropriate response depends on the underlying cause. New eye pain, redness, or changes in vision deserve prompt medical assessment.
Questions you could ask your doctor:
- Is this a known side effect of my medication?
- Could these symptoms be related to ulcerative colitis itself?
- Are there ways to address these effects without changing treatment?
- When would an alternative medication be considered?
- Which symptoms require urgent medical attention?
Do not stop or adjust prescribed medication without medical advice, except where you have been given specific emergency instructions. Suspected severe allergic reactions require emergency care.
What can you do if insurance delays a new ulcerative colitis treatment?
If insurance delays access to a prescribed medication, discussing the issue promptly with your healthcare team may help clarify available options and the approval process.
In the United States, access to advanced ulcerative colitis therapies can involve prior authorization, coverage restrictions, or substantial out-of-pocket costs.
Patients in mama health conversations described challenges such as:
- Insurance denials
- Delays in prior authorization
- Changes in insurance plans
- Loss of coverage for a medication that had previously worked
- Interruptions while waiting for treatment approval
Some patients described working with their healthcare teams on appeals or financial assistance applications.
Others reported that accessing affordable treatment remained difficult.
Coverage and financial support options vary by insurer, medication, and eligibility.
A healthcare team or specialty pharmacy may be able to explain available administrative support, manufacturer assistance programs, or other resources.
Questions you could ask your doctor or care team:
- Does this medication require prior authorization?
- Can your office help with insurance appeals or paperwork?
- Are financial assistance programs available?
- What happens if the approval process delays treatment?
- Is there a medically appropriate plan to discuss while coverage is being resolved?
Discussing these practical concerns early may reduce uncertainty around accessing prescribed care.
What if you've already tried several ulcerative colitis treatments?
Trying several medications without achieving lasting remission can be discouraging, but it does not automatically mean that no further treatment options remain.
Different medications affect different inflammatory pathways.
A person who does not respond to one biologic may still respond to another therapy, although the likelihood of benefit depends on individual circumstances and previous treatment history.
Current guidelines consider prior exposure to advanced therapies when evaluating subsequent treatment options. [2]
In mama health patient conversations, some people described trying several biologic or targeted oral therapies before finding one that helped them achieve remission.
Their experiences cannot predict what will happen for another person, but they illustrate how varied treatment journeys can be.
Patients also highlighted the importance of continuing prescribed maintenance therapy after finding a medication that worked.
Remission is an important goal, but long-term ulcerative colitis management also involves maintaining disease control.
Questions you could ask your doctor:
- Which treatment options have we not yet explored?
- What have we learned from my previous medication responses?
- Would a different mechanism of action be worth discussing?
- If we find an effective treatment, what will the maintenance plan involve?
When should worsening ulcerative colitis symptoms be treated as urgent?
Severe or rapidly worsening ulcerative colitis symptoms can require urgent medical attention rather than waiting for a routine appointment.
Warning signs include:
- Heavy or persistent rectal bleeding
- Severe abdominal pain
- A swollen or tender abdomen
- High fever
- Persistent vomiting
- Fainting, marked dizziness, or signs of dehydration
- Rapid deterioration in general health
Acute severe ulcerative colitis may require hospitalization and specialized treatment.
The Crohn's & Colitis Foundation advises seeking urgent medical care for severe symptoms such as heavy bleeding, significant abdominal pain, persistent vomiting, fever, or dehydration. [5]
If these symptoms occur, seek prompt medical assessment. Severe symptoms should not be managed simply by waiting for medication to take effect.
How can you prepare for your next gastroenterology appointment?
Preparing a short summary of your experiences and questions can make it easier to discuss concerns during an appointment.
You do not need to arrive with a treatment decision already made.
Instead, you might find it useful to reflect on:
- Which symptoms are most disruptive to your everyday life
- Whether symptoms have changed since starting your current medication
- Which side effects or practical difficulties concern you
- What you would like to understand about the available treatment options
- Which questions you most want answered
Some people find it helpful to bring a medication list, previous test results, or personal notes.
These materials can support an informed conversation with a healthcare professional.
Questions to take to your next appointment
- Treatment response: How do we know whether my medication is working?
- Disease activity: What tests could help explain my ongoing symptoms?
- Treatment failure: Why might this medication have stopped working?
- Alternatives: What other treatments could we discuss?
- Newer therapies: Are biologics or targeted oral medications relevant to my situation?
- Timing: When will we review the plan if symptoms continue?
- Side effects: Could my new symptoms be caused by medication or UC?
- Shared decisions: Can we discuss the benefits and risks of each option?
- Access: What can we do if insurance delays treatment?
- Long-term care: What is our goal for remission and maintenance therapy?
These questions are intended to support discussions, not to replace individualized medical advice.
Can you still achieve remission if your current UC treatment isn't working?
Yes. Some people with ulcerative colitis achieve remission after changing treatments, even when previous medications have not provided sufficient benefit.
However, treatment responses vary, and no medication can guarantee remission.
Living with symptoms that persist or return can be exhausting.
It can also create uncertainty about work, relationships, social plans, and the future.
In mama health patient conversations, frustration was a recurring part of the experience of living with ulcerative colitis.
Patients described feeling discouraged when medications stopped helping, but some also shared relief when they eventually found a treatment approach that worked for them.
One message emerges from these experiences: a treatment that hasn't worked does not mean that every other option will fail.
If you feel unsure about your current care, you can ask for an explanation, explore the alternatives with your gastroenterologist, or request another specialist's perspective.
The goal is not to find the newest medication at any cost.
It is to understand which evidence-based options may be appropriate for your individual situation and to participate in decisions about your care.
You deserve to feel informed, heard, and supported throughout that process.
Disclaimer: This content is informational and not a medical device. mama health offers information and support and does not replace a doctor.
This content is informational and is not medical advice.
mama health offers information and support and does not replace your doctor.
- American College of Gastroenterology (2025). Updated ACG Clinical Guidelines for Ulcerative Colitis in Adults. ACG guideline summary.
- Singh S, et al. (2024). AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. Gastroenterology. Guideline reviewed in March 2026 without amendments. AGA clinical guidance.
- American Gastroenterological Association (2017). Therapeutic Drug Monitoring in Inflammatory Bowel Disease. AGA clinical guidance.
- American Gastroenterological Association (2026). Management of Clostridioides difficile Infection in IBD: Clinical Practice Update. AGA clinical guidance.
- Crohn's & Colitis Foundation. Resources for IBD Flares. Patient resource.
- mama health patient conversations (United States): qualitative, paraphrased and anonymized insights. These accounts illustrate individual experiences and are not representative of everyone living with ulcerative colitis.
